A low red blood cell count means your body has fewer cells available to carry oxygen from your lungs to the rest of your tissues, a condition broadly called anemia. The consequences range from barely noticeable fatigue to serious organ strain, depending on how low the count drops and how quickly it fell. But a low number on a lab report is a starting point, not a diagnosis by itself. The underlying reasons span everything from a simple dietary shortfall to a bone marrow disorder, and figuring out which one matters more than the number alone.
How Your Body Decides How Many Red Blood Cells to Make
Your kidneys are the central regulators. They continuously monitor oxygen levels in the blood flowing through them and respond by adjusting production of a hormone called erythropoietin, or EPO. When oxygen delivery drops, specialized cells in the kidney ramp up EPO output, which travels to the bone marrow and signals it to produce more red blood cells. The kidney essentially acts as a sensor that balances red cell volume against plasma volume to keep oxygen delivery at an optimal level.
1PubMed. Why is erythropoietin made in the kidney? The kidney functions as a critmeterThe molecular trigger behind this is a protein complex called hypoxia-inducible factor, or HIF. Under normal oxygen conditions, HIF gets broken down almost immediately. When oxygen drops, HIF survives long enough to switch on the gene that produces EPO, and marrow production accelerates.
2PubMed Central. Regulation of erythropoietin production This feedback loop is why conditions that damage the kidneys or blunt this oxygen-sensing pathway can quietly cause anemia even when nothing else seems wrong.
Iron Deficiency, the Most Common Culprit
If you have a low red blood cell count, the single most likely explanation worldwide is iron deficiency. Iron is the core ingredient in hemoglobin, the protein inside red blood cells that actually binds oxygen. Without enough iron, the marrow still tries to make red blood cells, but they come out smaller and paler than normal, carrying less hemoglobin each. In a large cross-sectional survey of adolescents with low red cell indices, iron deficiency accounted for roughly a third of cases.
3PubMed. Haemoglobin variants, iron status and anaemia in Sri Lankan adolescents with low red cell indices: A cross sectional surveyThe causes of iron deficiency itself vary by age and sex. Menstrual blood loss is a major driver in people who have periods. In older adults, chronic low-grade bleeding from the gastrointestinal tract, sometimes from something as common as a stomach ulcer or a polyp, can slowly drain iron stores without producing any visible symptoms. Dietary intake matters too, but in well-nourished populations, unexplained iron deficiency in someone who is not menstruating always warrants a closer look at the GI tract.
Celiac disease deserves a specific mention here. Because celiac disease damages the lining of the upper small intestine, right where iron absorption occurs, people with undiagnosed celiac disease often present with stubborn iron deficiency anemia that does not respond well to oral supplements.
4PubMed Central. Iron deficiency anemia in celiac disease If you have been taking iron pills for months and your counts are not budging, your doctor may test for celiac disease or other malabsorption conditions.5Journal of Surgery & Anesthesia Research. Assessment of Iron Status and Iron Deficiency Anemia in Patients with Celiac Disease in Tripoli University Hospital
Vitamin B12 and Folate Deficiency
Iron gets most of the attention, but your bone marrow also needs vitamin B12 and folate to build red blood cells properly. Both vitamins are essential for DNA synthesis inside the rapidly dividing cells of the marrow. When either one is missing, the marrow produces abnormally large, immature red blood cells that do not function well and die off faster than they should.
B12 deficiency tends to develop slowly, because the body stores several years’ worth in the liver. People who eat very little animal protein, those who have had gastric surgery, and older adults with reduced stomach acid production are at higher risk. Folate deficiency can develop faster, since stores are smaller, and is more common in people with poor diets or heavy alcohol use. The two deficiencies produce similar-looking blood results but require different treatment, so distinguishing them matters. Research has confirmed that the underlying biochemical defect differs: in B12 deficiency, a specific folate form cannot be properly utilized, which impairs the cell’s ability to make DNA building blocks. Folate supplementation can mask the blood abnormalities of B12 deficiency while the neurological damage from B12 deficiency continues, which is why testing for both is standard practice.
6Blood. The effect of folate analogues and vitamin B12 on provision of thymine nucleotides for DNA synthesis in megaloblastic anemiaWhen Chronic Illness Quietly Suppresses Red Cell Production
One of the trickier causes is what clinicians call anemia of chronic disease. This happens when the body’s inflammatory response, triggered by infections, autoimmune conditions like rheumatoid arthritis, or chronic kidney disease, interferes with iron metabolism even when total iron stores in the body are adequate. The mechanism centers on a liver protein called hepcidin. During inflammation, the body produces more hepcidin, which blocks the release of iron from storage cells and reduces iron absorption from the gut. The result is that iron gets locked away where the bone marrow cannot use it.
7European Journal of Internal Medicine. Anemia of chronic disease: Everyone’s focusThis type of anemia is usually mild to moderate and develops gradually. Because the iron is technically there, just sequestered, standard iron supplements often do not help much. The anemia tends to improve when the underlying inflammatory condition is treated. Hepcidin’s role in regulating iron is now central to how researchers understand anemia in the setting of chronic illness.
8PubMed Central. Role of hepcidin in the pathophysiology and diagnosis of anemiaBone Marrow Problems and Cancer Treatment
Sometimes the factory itself is the problem. The bone marrow can fail to produce enough red blood cells due to diseases that crowd out normal blood-forming cells, like leukemia or myelodysplastic syndromes, or because the marrow has been damaged by toxins, radiation, or medications. Aplastic anemia, where the marrow essentially shuts down production of all blood cell types, is rare but serious.
Cancer treatment is a common and often expected cause of a dropping red blood cell count. Chemotherapy drugs target rapidly dividing cells, and marrow cells are among the fastest-dividing in the body. In patients receiving chemotherapy, decreased red blood cell production from marrow suppression is the dominant factor, though iron deficiency frequently coexists.
9PubMed Central. Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches This layering of causes is part of what makes anemia in cancer patients particularly challenging to manage.
Blood Loss and Red Cell Destruction
A low red blood cell count does not always mean the marrow is underperforming. Sometimes the body is losing red blood cells faster than it can replace them. Acute blood loss from surgery, trauma, or a major GI bleed can drop counts rapidly. Chronic, slower blood loss from heavy menstrual periods, stomach ulcers, or colon polyps drains iron stores over time and eventually leads to the iron deficiency anemia described above.
In other cases, the red blood cells are being destroyed prematurely once they enter the bloodstream. This is called hemolytic anemia, and it has several forms. One of the more striking is autoimmune hemolytic anemia, where the immune system mistakenly produces antibodies against the body’s own red blood cells, flagging them for destruction.
10Asian Journal of Medical Sciences. Role of direct antiglobulin test in assessing the severity of extravascular hemolysis in autoimmune hemolytic anemia – analysis from a cross-sectional study Autoimmune hemolytic anemia comes in two main subtypes depending on the temperature at which the offending antibodies are most active: warm antibody AIHA accounts for roughly 60 to 70 percent of cases, while cold agglutinin disease makes up about 20 to 25 percent.11Blood. Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA) Inherited conditions like sickle cell disease and thalassemia also shorten red blood cell lifespan, though these are typically identified much earlier in life.
What a Low Count Actually Feels Like
Mild anemia is often invisible. The body compensates remarkably well by increasing heart rate, redirecting blood flow, and extracting more oxygen per red blood cell. You might feel slightly more winded climbing stairs or notice you tire earlier in a workout, but many people with mild anemia have no symptoms at all.
As the count drops further, the compensatory mechanisms start to strain. Fatigue that rest does not fix, dizziness on standing, a rapid or pounding heartbeat, pale skin, and cold hands and feet are classic signs. The brain is particularly sensitive. When hemoglobin falls, blood vessels in the brain dilate to try to maintain oxygen delivery, but beyond a certain point this compensation fails and cognitive function suffers.
12PubMed Central. The Impact of Low Hemoglobin Levels on Cognitive Brain FunctionsResearch in older women has found that even mild anemia is associated with measurably worse performance on tests of executive function, the mental skills involved in planning, multitasking, and problem-solving. In one study, women with hemoglobin between 10 and 12 g/dL were substantially less likely to score in the top tier on cognitive tests compared to women with hemoglobin above 12 g/dL, even after adjusting for other health factors.
13Blood. Association of Mild Anemia and Executive Cognitive Function Impairment in High Functioning Community-Dwelling Older Women This raises a practical concern: if you or an older family member has been chalking up mental fogginess to “just getting older,” a simple blood count is worth requesting.
When Low Counts Are Not What They Seem
Before you worry about a low red blood cell count on a lab report, it is worth knowing that the number can be artificially low due to how the blood sample was collected. Research on pre-analytical factors has shown that if a blood tube is overfilled beyond the intended volume, the measured hemoglobin, hematocrit, red blood cell count, and mean cell volume can all read lower than they actually are.
14Diagnostyka Laboratoryjna. The influence of the preanalytical factors on the results of a Complete Blood Count Drawing blood from an arm that has an IV line running in it can dilute the sample with IV fluid, producing falsely low results. Prolonged tourniquet time can also shift fluid balance in the vein. If a result seems unexpectedly low and you had no symptoms, your doctor may simply recheck it before launching into a workup.
How Doctors Figure Out the Cause
The first clue usually comes from a standard complete blood count, which not only tells you the red cell count and hemoglobin level but also reports the average size of your red blood cells, a measurement called mean corpuscular volume, or MCV. Red blood cell size is a surprisingly useful diagnostic shortcut:
- Small cells (low MCV): This pattern points most often toward iron deficiency or inherited hemoglobin conditions like thalassemia. In one study of blood donors with low MCV, iron deficiency accounted for about two-thirds of cases, while the rest had a hemoglobin variant or both. 15PubMed Central. Evaluation of low red blood cell mean corpuscular volume in an apheresis donor population
- Normal-sized cells (normal MCV): This is the pattern in anemia of chronic disease, acute blood loss, kidney disease, and many bone marrow disorders.
- Large cells (high MCV): B12 or folate deficiency, certain medications, liver disease, and hypothyroidism are common causes.
From there, additional tests like iron studies, B12 and folate levels, a reticulocyte count (which measures how many young red blood cells the marrow is releasing), kidney function tests, and inflammatory markers help narrow the field. Occasionally, a bone marrow biopsy is needed when the cause remains unclear after standard blood work.
Anemia in Older Adults Can Be Stubbornly Unexplained
Anemia becomes more common with age, and one of the more frustrating findings in geriatric medicine is that a large proportion of anemia in older adults resists explanation. Even after thorough workups including bone marrow biopsies, roughly 40 to 44 percent of anemia in elderly patients falls into the category of “unexplained anemia of aging.”
16PubMed Central. Unexplained anemia of aging: Etiology, health consequences, and diagnostic criteriaResearch characterizing this condition has found that it tends to produce normal-sized red blood cells with a sluggish marrow response and EPO levels that are lower than expected for the degree of anemia. One hypothesis is that the oxygen-sensing pathway in the kidney deteriorates with age, blunting the EPO signal that would normally tell the marrow to ramp up production.
17Blood. Unexplained Anemia Is Common in Elderly Patients with Anemia and Is Characterized by a Low Erythropoietin Level In a racially diverse cohort of older adults, unexplained anemia was the single largest category at about 44 percent of cases, with iron deficiency a distant second at 25 percent.18Blood. Unexplained Anemia In the Elderly (UAE) Predominates as the Major Anemia Category In Racially Diverse Cohort of Older Persons Despite An Intensive Evaluation The anemia is usually mild and rarely requires transfusion, but it is associated with worse physical function and quality of life, making it clinically relevant even when the numbers look only slightly low.
Athletes and the Misleading “Sports Anemia”
Endurance athletes sometimes turn up with low red blood cell counts or low hemoglobin on routine labs, which can be alarming. In many cases, though, this reflects a harmless expansion of plasma volume: the blood is more diluted, so the concentration of red blood cells per unit of blood drops, even though the total number of red blood cells in the body is normal or even increased. This “dilution anemia” requires no treatment.
That said, not all low counts in athletes are benign. Long-distance runners in particular can develop genuine hemolytic anemia from repeated foot strikes mechanically destroying red blood cells in the capillaries of the feet, a phenomenon documented in ultramarathon runners.
19PubMed Central. Foot-strike haemolysis in an ultramarathon runner Trace GI bleeding during prolonged exercise is another recognized contributor. If you are a serious endurance athlete with persistently low counts and declining performance, it is worth getting iron studies rather than assuming the number is just a training artifact.
How Low Counts Are Treated
Treatment depends entirely on the cause, which is why the diagnostic workup matters so much. For iron deficiency, oral iron supplements are the usual first step. When oral iron is not absorbed well or is not tolerated due to GI side effects, intravenous iron is an effective alternative and is generally the preferred route for patients with complex medical conditions or concurrent functional iron deficiency.
20PubMed Central. How I treat anemia with red blood cell transfusion and ironB12 deficiency is treated with B12 injections or high-dose oral supplements. Folate deficiency responds to folic acid tablets. Anemia of chronic disease usually improves when the underlying condition is managed. For bone marrow disorders, treatment may involve medications that stimulate blood cell production, immunosuppressive therapy, or in severe cases, a bone marrow transplant.
Red blood cell transfusion is reserved for more severe or acute situations. Clinical trials have shown that a conservative transfusion threshold, giving blood when hemoglobin drops to 7 or 8 g/dL rather than 9 or 10 g/dL, is as safe as a more liberal approach in many settings.
20PubMed Central. How I treat anemia with red blood cell transfusion and iron This finding has shifted clinical practice toward transfusing less often and focusing more on treating the root cause.
Medications That Can Lower Your Count
A surprising number of common medications can contribute to a low red blood cell count through various mechanisms. Nonsteroidal anti-inflammatory drugs like ibuprofen can cause GI bleeding that drains iron stores over time. Certain antibiotics and anticonvulsants interfere with folate metabolism. Proton pump inhibitors, widely used for acid reflux, reduce stomach acid enough to impair absorption of both iron and B12 over years of use. Methotrexate, used in autoimmune diseases, directly suppresses marrow activity. Chemotherapy drugs, as noted earlier, are expected to cause drops.
If you are on a long-term medication and your red blood cell count has been trending downward, mentioning the medication to whoever ordered the blood work is useful information. Sometimes the fix is as simple as adding a supplement or adjusting the dose, rather than launching into an extensive workup for a rare condition.